USANA HEALTH SCIENCES, INC. Cash and Cash Equivalents, Period Increase (Decrease)
USANA HEALTH SCIENCES, INC. (USNA) reported Cash and Cash Equivalents, Period Increase (Decrease) of $71.36 million for the 12-month period ending 2017-12-30, per its 10-K filed 2018-02-28.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-02-28
- USANA HEALTH SCIENCES, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-30 was $55.39M, a 34.33% increase year-over-year.
- USANA HEALTH SCIENCES, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-09-30 was -$37.62M, a 269.88% decline year-over-year.
- USANA HEALTH SCIENCES, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-07-01 was $53.05M.
- USANA HEALTH SCIENCES, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-04-01 was $546.00K, a 92.51% decline year-over-year.
- USANA HEALTH SCIENCES, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $71.36M, a 119.13% increase from fiscal 2016.
- USANA HEALTH SCIENCES, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $32.56M, a 1.50% increase from fiscal 2016.
- USANA HEALTH SCIENCES, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $32.08M.
- USANA HEALTH SCIENCES, INC. cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$26.22M, a 139.42% decline from fiscal 2013.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2017-12-30 | $55.39M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $17.77M derived: sum of 2 quarters · filed 2018-02-28 | $70.81M derived: sum of 3 quarters · filed 2018-02-28 | $71.36M 10-K · filed 2018-02-28 |
| 2017-09-30 | -$37.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $15.43M derived: sum of 2 quarters · filed 2017-11-08 | $15.97M 10-Q · filed 2017-11-08 | $57.20M derived: sum of 4 quarters · filed 2018-02-28 |
| 2017-07-01 | $53.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $53.59M 10-Q · filed 2017-08-09 | $94.82M derived: sum of 3 quarters · filed 2018-02-28 | $116.97M derived: sum of 4 quarters · filed 2018-02-28 |
| 2017-04-01 | $546.00K 10-Q · filed 2017-05-10 | $41.78M derived: sum of 2 quarters · filed 2018-02-28 | $63.92M derived: sum of 3 quarters · filed 2018-02-28 | $25.82M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-12-31 | $41.23M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $63.38M derived: sum of 2 quarters · filed 2018-02-28 | $25.27M derived: sum of 3 quarters · filed 2018-02-28 | $32.56M 10-K · filed 2018-02-28 |
| 2016-10-01 | $22.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$15.96M derived: sum of 2 quarters · filed 2017-11-08 | -$8.67M 10-Q · filed 2017-11-08 | -$39.65M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-07-02 | -$38.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$30.81M 10-Q · filed 2017-08-09 | -$61.80M derived: sum of 3 quarters · filed 2018-02-28 | -$38.53M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-04-02 | $7.29M 10-Q · filed 2017-05-10 | -$23.69M derived: sum of 2 quarters · filed 2018-02-28 | -$428.00K derived: sum of 3 quarters · filed 2018-02-28 | $21.93M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-01-02 | -$30.98M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | -$7.72M derived: sum of 2 quarters · filed 2018-02-28 | $14.64M derived: sum of 3 quarters · filed 2018-02-28 | $32.08M 10-K · filed 2018-02-28 |
| 2015-10-03 | $23.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $45.63M derived: sum of 2 quarters · filed 2016-11-09 | $63.07M 10-Q · filed 2016-11-09 | $86.46M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-07-04 | $22.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $39.80M 10-Q · filed 2016-08-09 | $63.19M derived: sum of 3 quarters · filed 2017-03-01 | $32.66M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-04-04 | $17.44M 10-Q · filed 2016-05-11 | $40.83M derived: sum of 2 quarters · filed 2017-03-01 | $10.30M derived: sum of 3 quarters · filed 2017-03-01 | -$14.16M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-01-03 | $23.39M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$7.14M derived: sum of 2 quarters · filed 2017-03-01 | -$31.61M derived: sum of 3 quarters · filed 2017-03-01 | -$26.22M 10-K · filed 2017-03-01 |
| 2014-09-27 | -$30.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$54.99M derived: sum of 2 quarters · filed 2015-11-12 | -$49.60M 10-Q · filed 2015-11-12 | -$27.61M derived: sum of 4 quarters · filed 2016-03-01 |
| 2014-06-28 | -$24.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | -$19.08M 10-Q · filed 2015-08-12 | $2.92M derived: sum of 3 quarters · filed 2016-03-01 | $22.21M derived: sum of 4 quarters · filed 2016-03-01 |
| 2014-03-29 | $5.39M 10-Q · filed 2015-05-13 | $27.38M derived: sum of 2 quarters · filed 2016-03-01 | $46.68M derived: sum of 3 quarters · filed 2016-03-01 | $71.69M derived: sum of 4 quarters · filed 2016-03-01 |
| 2013-12-28 | $21.99M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01 | $41.29M derived: sum of 2 quarters · filed 2016-03-01 | $66.30M derived: sum of 3 quarters · filed 2016-03-01 | $66.50M 10-K · filed 2016-03-01 |
| 2013-09-28 | $19.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $44.30M derived: sum of 2 quarters · filed 2014-11-06 | $44.51M 10-Q · filed 2014-11-06 | $38.75M derived: sum of 4 quarters · filed 2015-03-17 |
| 2013-06-29 | $25.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $25.22M 10-Q · filed 2014-08-05 | $19.45M derived: sum of 3 quarters · filed 2015-03-17 | $30.52M derived: sum of 4 quarters · filed 2015-03-17 |
| 2013-03-30 | $208.00K 10-Q · filed 2014-05-07 | -$5.55M derived: sum of 2 quarters · filed 2015-03-17 | $5.51M derived: sum of 3 quarters · filed 2015-03-17 | -$117.00K derived: sum of 4 quarters · filed 2015-03-17 |
| 2012-12-29 | -$5.76M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-17 | $5.30M derived: sum of 2 quarters · filed 2015-03-17 | -$325.00K derived: sum of 3 quarters · filed 2015-03-17 | $20.49M 10-K · filed 2015-03-17 |
| 2012-09-29 | $11.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $5.44M derived: sum of 2 quarters · filed 2013-11-07 | $26.25M 10-Q · filed 2013-11-07 | $40.28M derived: sum of 4 quarters · filed 2014-03-13 |
| 2012-06-30 | -$5.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $15.19M 10-Q · filed 2013-08-08 | $29.22M derived: sum of 3 quarters · filed 2014-03-13 | $40.59M derived: sum of 4 quarters · filed 2014-03-13 |
| 2012-03-31 | $20.81M 10-Q · filed 2013-05-07 | $34.85M derived: sum of 2 quarters · filed 2014-03-13 | $46.22M derived: sum of 3 quarters · filed 2014-03-13 | $38.45M derived: sum of 4 quarters · filed 2014-03-13 |
| 2011-12-31 | $14.04M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $25.41M derived: sum of 2 quarters · filed 2014-03-13 | $17.64M derived: sum of 3 quarters · filed 2014-03-13 | $26.13M 10-K · filed 2014-03-13 |
| 2011-10-01 | $11.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $3.60M derived: sum of 2 quarters · filed 2012-11-07 | $12.10M 10-Q · filed 2012-11-07 | $13.39M derived: sum of 4 quarters · filed 2013-03-11 |
| 2011-07-02 | -$7.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $722.00K 10-Q · filed 2012-08-08 | $2.02M derived: sum of 3 quarters · filed 2013-03-11 | -$3.48M derived: sum of 4 quarters · filed 2013-03-11 |
| 2011-04-02 | $8.50M 10-Q · filed 2012-05-10 | $9.79M derived: sum of 2 quarters · filed 2013-03-11 | $4.29M derived: sum of 3 quarters · filed 2013-03-11 | |
| 2011-01-01 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | -$4.21M derived: sum of 2 quarters · filed 2013-03-11 | $10.56M 10-K · filed 2013-03-11 | |
| 2010-10-02 | -$5.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $9.27M 10-Q · filed 2011-11-09 | ||
| 2010-07-03 | $14.77M 10-Q · filed 2011-08-10 | |||
| 2010-01-02 | $377.00K 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |